Evaluation of Clinical Studies of Patients With Dermatophyte Infections Caused by Trichophyton indotineae: Treatment Response and Resistance to Antifungal Medications
Keywords:
Dermatophytosis, Treatment, Trichophyton indotineaeAbstract
Introduction: As the pandemic plateaus, post-COVID alopecia is resurfacing in India. COVID-19 remains a pivotal cause of alopecia, and the diagnosis of post-COVID alopecia aids in better treatment outcomes.
Objectives: To estimate the prevalence of post-COVID alopecia and to evaluate the association between alopecia and COVID severity among other factors.
Methods: A retrospective cross-sectional study was conducted among patients admitted to the COVID ward. Patients willing to participate were asked to fill in a pretested semi-structured questionnaire, and the PSS-10 (Perceived Stress Scale) was used to evaluate stress. Data were analyzed using the SPSS version 24.
Results: Prevalence of COVID-19-induced hair loss was 37.8%. Age, sex, COVID severity, and higher stress were the significant factors, with p-value <0.05. Female sex, COVID severity, and high stress levels came to be significant independent predictors of hair loss. A majority of participants (46.9%) noticed hair loss within three months of contracting the disease.
Conclusion: This study stands to be a pioneer project to investigate the prevalence of COVID-19-induced alopecia in India. The prevalence rate of 37.8% with a significant association with severity of COVID-19 highlights the importance of reviewing patient history to provide proper treatment and reassurance.
References
Liang G, Li X, Li R, et al. Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition). Mycoses. 2024;67(9):e13785. DOI: 10.1111/myc.13785. PMID: 39245647.
Gold JAW, Benedict K, Lockhart SR, et al. Recognition of antifungal-resistant dermatophytosis by infectious diseases specialists, United States. Emerg Infect Dis. 2024;30(9):1978-1980. DOI: 10.3201/eid3009.240118. PMID: 39174019.
Uhrlaß S, Verma SB, Gräser Y, et al. Trichophyton indotineae-an emerging pathogen causing recalcitrant dermatophytoses in India and worldwide-a multidimensional perspective. J Fungi (Basel). 2022;8(7):757. DOI: 10.3390/jof8070757. PMID: 35887512.
Ferreira CB, Lisboa C. A systematic review on the emergence of terbinafine-resistant Trichophyton indotineae in Europe: time to act? J Eur Acad Dermatol Venereol. 2024. Published online. DOI: 10.1111/jdv.20270. PMID: 39082800.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. DOI: 10.1136/bmj.n71. PMID: 33782057.
Kano R, Kimura U, Kakurai M, et al. Trichophyton indotineae sp. nov.: a new highly terbinafine-resistant anthropophilic dermatophyte species. Mycopathologia. 2020;185(6):947-958. DOI: 10.1007/s11046-020-00455-8. PMID: 32449054.
Khurana A, Agarwal A, Singh A, et al. Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-a prospective trial. Mycoses. 2021;64(12):1480-1488. DOI: 10.1111/myc.13367. PMID: 34532888.
Pashootan N, Shams-Ghahfarokhi M, Chaichi Nusrati A, Salehi Z, Asmar M, Razzaghi-Abyaneh M. Phylogeny, antifungal susceptibility, and point mutations of SQLE gene in major pathogenic dermatophytes isolated from clinical dermatophytosis. Front Cell Infect Microbiol. 2022;12:851769. DOI: 10.3389/fcimb.2022.851769. PMID: 35372131.
Moreno-Sabater A, Normand AC, Bidaud AL, et al. Terbinafine resistance in dermatophytes: a French multicenter prospective study. J Fungi (Basel). 2022;8(3):220. DOI: 10.3390/jof8030220. PMID: 35330222.
Astvad KMT, Hare RK, Jørgensen KM, Saunte DML, Thomsen PK, Arendrup MC. Increasing terbinafine resistance in danish Trichophyton isolates 2019-2020. J Fungi (Basel). 2022;8:801. DOI: 10.3390/jof8020150. PMID: 35205904.
Posso-De Los Rios CJ, Tadros E, Summerbell RC, Scott JA. Terbinafine resistant Trichophyton indotineae isolated in patients with superficial dermatophyte infection in Canadian patients. J Cutan Med Surg. 2022;26(4):371-376. DOI: 10.1177/12034754221077891. PMID: 35144480.
Jia S, Long X, Hu W, et al. The epidemic of the multiresistant dermatophyte Trichophyton indotineae has reached China. Front Immunol. 2022;13:1113065. DOI: 10.3389/fimmu.2022.1113065. PMID: 36874152.
Bortoluzzi P, Prigitano A, Sechi A, et al. Report of terbinafine resistant Trichophyton spp. in Italy: clinical presentations, molecular identification, antifungal susceptibility testing and mutations in the squalene epoxidase gene. Mycoses. 2023;66(8):680-687. DOI: 10.1111/myc.13597. PMID: 37139949.
Kong X, Song G, Mei H, et al. The domestic isolation of terbinafine- and itraconazole-resistant Trichophyton indotineae in Chinese Mainland. Mycopathologia. 2023;188(4):383-393. DOI: 10.1007/s11046-023-00761-x. PMID: 37335400.
Tamimi P, Fattahi M, Firooz A, et al. Recalcitrant dermatophyte infections: identification and risk factors. Int J Dermatol. 2024;63(10):1398-1403. DOI: 10.1111/ijd.17145. PMID: 38712801.
Caplan AS, Todd GC, Zhu Y, et al. Clinical course, antifungal susceptibility, and genomic sequencing of Trichophyton indotineae. JAMA Dermatol. 2024;160(7):701-709. DOI: 10.1001/jamadermatol.2024.1126. PMID: 38748419.
Ngo TMC, Santona A, Ton Nu PA, et al. Detection of terbinafine-resistant Trichophyton indotineae isolates within the Trichophyton mentagrophytes species complex isolated from patients in Hue City, Vietnam: a comprehensive analysis. Med Mycol. 2024;62(8):myae088. DOI: 10.1093/mmy/myae088. PMID: 39174488.
Hiruma J, Kimura U, Noguchi H, Hiruma M, Harada K, Kano R. In vitro azole susceptibility testing of Japanese isolates of terbinafine-resistant Trichophyton indotineae and Trichophyton rubrum. Med Mycol J. 2023;64(1):23-5. DOI: 10.3314/mmj.22-00021. PMID: 36858630.
Dellière S, Joannard B, Benderdouche M, et al. Emergence of difficult-to-treat tinea corporis caused by Trichophyton mentagrophytes complex isolates, Paris, France. Emerg Infect Dis. 2022;28(1):224-228. DOI: 10.3201/eid2801.210810. PMID: 34932462.
Jabet A, Brun S, Normand AC, et al. Extensive dermatophytosis caused by terbinafine-resistant Trichophyton indotineae, France. Emerg Infect Dis. 2022;28(1):229-233. DOI: 10.3201/eid2801.210883. PMID: 34932456.
Ngo TMC, Ton Nu PA, Le CC, Ha TNT, Do TBT, Tran Thi G. First detection of Trichophyton indotineae causing tinea corporis in Central Vietnam. Med Mycol Case Rep. 2022;36:37-41. DOI: 10.1016/j.mmcr.2022.05.004. PMID: 35620657.
Durdu M, Kandemir H, Karakoyun AS, Ilkit M, Tang C, de Hoog S. First terbinafine-resistant Trichophyton indotineae isolates with Phe(397)Leu and/or Thr(414)His mutations in Turkey. Mycopathologia. 2023;188(1):2. DOI: 10.1007/s11046-023-00708-2. PMID: 36656402.
Caplan AS, Chaturvedi S, Zhu Y, et al. Notes from the field: first reported U.S. cases of tinea caused by Trichophyton indotineae-New York City, December 2021-March 2023. MMWR Morb Mortal Wkly Rep. 2023;72(19):536-537. DOI: 10.15585/mmwr.mm7219a4. PMID: 37167192.
Russo G, Toutous Trellu L, Fontao L, Ninet B. Towards an early clinical and biological resistance detection in dermatophytosis: about 2 cases of Trichophyton indotineae. J Fungi (Basel). 2023;9(7):733. DOI: 10.3390/jof9070733. PMID: 37504722.
Dashti Y, Alobaid K, Al-Rashidi S, et al. Autochthonous case of Trichophyton indotineae in Kuwait. J Mycol Med. 2023;33(4):101432. DOI: 10.1016/j.mycmed.2023.101432. PMID: 37666031.
Messina F, Santiso G, Romero M, Bonifaz A, Fernandez M, Marin E. First case report of tinea corporis caused by Trichophyton indotineae in Latin America. Med Mycol Case Rep. 2023;41:48-51. DOI: 10.1016/j.mmcr.2023.08.004. PMID: 37706043.
Crotti S, Cruciani D, Spina S, et al. A terbinafine sensitive Trichophyton indotineae strain in Italy: the first clinical case of tinea corporis and onychomycosis. J Fungi (Basel). 2023;9(9):865. DOI: 10.3390/jof9090865. PMID: 37754973.
Thakur R, Kushwaha P, Kalsi AS. Tinea universalis due to Trichophyton indotineae in an adult male. Indian J Med Microbiol. 2023;46:100476. DOI: 10.1016/j.ijmmb.2023.100476. PMID: 37806168.
Pavlović MD, Marzouk S, Bećiri L. Widespread dermatophytosis in a healthy adolescent: the first report of multidrug-resistant Trichophyton indotineae infection in the UAE. Acta Dermatovenerol Alp Pannonica Adriat. 2024;33(1):53-55. DOI: 10.15570/actaapa.2024.4. PMID: 38347717.
Teo JWP, Cheng JWS, Chew KL, Lin RTP. Whole genome characterization of Trichophyton indotineae isolated in Singapore. Med Mycol. 2024;62(2):myae012. DOI: 10.1093/mmy/myae012. PMID: 38366631.
Fukada N, Kobayashi H, Nakazono M, et al. A case of tinea faciei due to Trichophyton indotineae with steroid rosacea related to topical over-the-counter drugs purchased outside of Japan. Med Mycol J. 2024;65(1):23-26. DOI: 10.3314/mmj.23-00014. PMID: 38417884.
Spivack S, Gold JAW, Lockhart SR, et al. Potential sexual transmission of antifungal-resistant Trichophyton indotineae. Emerg Infect Dis. 2024;30(4):807-809. DOI: 10.3201/eid3004.240115. PMID: 38437706.
Tamimi P, Fattahi M, Ghaderi A, et al. Terbinafine-resistant T. indotineae due to F397L/L393S or F397L/L393F mutation among corticoid-related tinea incognita patients. J Dtsch Dermatol Ges. 2024;22(7):922-934. DOI: 10.1111/ddg.15440. PMID: 38924688.
Madarasingha NP, Thabrew H, Uhrlass S, et al. Dermatophytosis caused by Trichophyton indotineae (Trichophyton mentagrophytes ITS Genotype VIII) in Sri Lanka. Am J Trop Med Hyg. 2024;111(3):575-577. DOI: 10.4269/ajtmh.24-0027. PMID: 38981494.
Chua KY, Halliday CL, Chen SC, et al. Treatment-resistant tinea caused by Trichophyton indotineae in Australia. Med J Aust. 2024;221(4):192-194. DOI: 10.5694/mja2.52386. PMID: 39013435.
Smith A, Wong-O'Brien B, Lieberman JA, Cookson BT, Grinager E, Truong TT. The brief case: a case of tinea corporis caused by drug-resistant Trichophyton indotineae identified by broad-range fungal DNA sequencing. J Clin Microbiol. 2024;62(8):e0023424. DOI: 10.1128/jcm.00234-24. PMID: 39140757.
Mochizuki T, Anzawa K, Bernales-Mendoza AM, Shimizu A. Case of tinea corporis caused by a terbinafine-sensitive Trichophyton indotineae strain in a Vietnamese worker in Japan. J Dermatol. 2024. Published online. DOI: 10.1111/1346-8138.17463. PMID: 39269204.
Tan TY, Wang YS, Wong XYA, et al. First reported case of Trichophyton indotineae dermatophytosis in Singapore. Pathology. 2024;56(6):909-913. DOI: 10.1016/j.pathol.2024.04.003. PMID: 38937185.
Carroll E, Leahy M, Stanciu M, Laing M. Trichophyton indotineae: first case in Ireland and response to topical griseofulvin. Clin Exp Dermatol. 2024;49(12):1707-1708. DOI: 10.1093/ced/llae264. PMID: 39005069.
Gueneau R, Joannard B, Haddad N, et al. Extensive dermatophytosis caused by terbinafine-resistant Trichophyton indotineae, successfully treated with topical voriconazole. Int J Antimicrob Agents. 2022;60(5-6):106677. DOI: 10.1016/j.ijantimicag.2022.106677. PMID: 36184016.
Villa-Gonzalez JM, Pascual Ares M, López-Soria LM, Gonzalez-Hermosa MR, Gardeazabal García J, Lasa Elgezua O. Extensive tinea corporis caused by Trichophyton indotineae: report of a case in Spain. J Eur Acad Dermatol Venereol. 2024;38(1):e22-23. DOI: 10.1111/jdv.19404. PMID: 37556851.
Xie W, Kong X, Zheng H, et al. Rapid emergence of recalcitrant dermatophytosis caused by a cluster of multidrug-resistant Trichophyton indotineae in China. Br J Dermatol. 2024;190(4):585-587. DOI: 10.1093/bjd/ljae009. PMID: 38180270.
Abdolrasouli A, Borman AM, Johnson EM, Hay RJ, Arias M. Terbinafine-resistant Trichophyton indotineae causing extensive dermatophytosis in a returning traveller, London, UK. Clin Exp Dermatol. 2024;49(6):635-637. DOI: 10.1093/ced/llae042. PMID: 38320217.
Bui TS, Chan JB, Katz KA. Extensive multidrug-resistant dermatophytosis from Trichophyton indotineae. Cutis. 2024;113(6):E20-23. DOI: 10.12788/cutis.1050. PMID: 39082990.
Sonego B, Corio A, Mazzoletti V, et al. Trichophyton indotineae, an emerging drug-resistant dermatophyte: a review of the treatment options. J Clin Med. 2024;13(12):3558. DOI: 10.3390/jcm13123558. PMID: 38930086.
Jabet A, Normand AC, Brun S, et al. Trichophyton indotineae, from epidemiology to therapeutic. J Mycol Med. 2023;33(3):101383. DOI: 10.1016/j.mycmed.2023.101383. PMID: 37031652.
Hui ST, Gifford H, Rhodes J. Emerging antifungal resistance in fungal pathogens. Curr Clin Microbiol Rep. 2024;11(2):43-50. DOI: 10.1007/s40588-024-00219-8. PMID: 38725545.
Published
Issue
Section
License
Copyright (c) 2025 Funda Tamer, Muhterem Polat
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
